PRCC
Proline-rich protein PRCC
Also known as: PRCC_HUMAN, RCCP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q92733
- Gene
- PRCC
- Ensembl
- ENSG00000143294
- Chromosome
- 1
- Canonical length
- 491 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nuclear speckles
OverviewNCBI Gene
This gene encodes a protein that may play a role in pre-mRNA splicing. Chromosomal translocations (X;1)(p11;q21) that result in fusion of this gene to TFE3 (GeneID 7030) have been associated with papillary renal cell carcinoma. A PRCC-TFE3 fusion protein is expressed in affected carcinomas and is likely associated with altered gene transactivation. This fusion protein has also been associated with disruption of the cell cycle.[provided by RefSeq, Aug 2010]
Canonical amino-acid sequenceUniProt
491 residues, UniProt reviewed canonical sequence.
>Q92733|PRCC
1 MSLVAYASSD ESEPDEAEPE PEEEEAVAPT SGPALGGLFA SLPAPKGPAL LPPPPQMLAP
61 AFPPPLLLPP PTGDPRLQPP PPLPFGLGGF PPPPGVSPAE AAGVGEGLGL GLPSPRGPGL
121 NLPPPIGGAG PPLGLPKPKK RKEPVKIAAP ELHKGDSDSE EDEPTKKKTI LQGSSEGTGL
181 SALLPQPKNL TVKETNRLLL PHAFSRKPSD GSPDTKPSRL ASKTKTSSLA PVVGTTTTTP
241 SPSAIKAAAK SAALQVTKQI TQEEDDSDEE VAPENFFSLP EKAEPPGVEP YPYPIPTVPE
301 ELPPGTEPEP AFQDDAANAP LEFKMAAGSS GAPWMPKPGD DYSYNQFSTY GDANAAGAYY
361 QDYYSGGYYP AQDPALVPPQ EIAPDASFID DEAFKRLQGK RNRGREEINF VEIKGDDQLS
421 GAQQWMTKSL TEEKTMKSFS KKKGEQPTGQ QRRKHQITYL IHQAKERELE LKNTWSENKL
481 SRRQTQAKYG FLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PRCC can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.68
- Highest tissue expression
- 62 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 62 nTPM
- skin: 42 nTPM
- cerebellum: 40 nTPM
- bone marrow: 40 nTPM
- choroid plexus: 39 nTPM
- esophagus: 39 nTPM
Single-cell type
- syncytiotrophoblasts: 136 nCPM
- migrating cytotrophoblasts: 87 nCPM
- extravillous trophoblasts: 82 nCPM
- cytotrophoblasts: 80 nCPM
- esophageal apical cells: 66 nCPM
- plasma cells: 63 nCPM
Immune cell
- eosinophil: 58 nTPM
- basophil: 47 nTPM
- plasmacytoid DC: 39 nTPM
- non-classical monocyte: 37 nTPM
- myeloid DC: 33 nTPM
- NK-cell: 30 nTPM
Brain region
- white matter: 49 nTPM
- cerebral cortex: 47 nTPM
- cerebellum: 45 nTPM
- basal ganglia: 45 nTPM
- hippocampal formation: 44 nTPM
- pons: 44 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 1.09
- DepMap mean gene effect
- -0.41
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 18% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Proline-rich protein PRCC
- Mitotic checkpoint regulator, MAD2B-interacting
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PRCC in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PRCC as an antibody target. Whether an autoantibody or antibody against PRCC could matter depends on whether native PRCC is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PRCC is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PRCC as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...